Takeda, Endo, Teva, Amneal Face Antitrust Lawsuit Over Gout Drug

Affiliates of Takeda Pharmaceutical Co., Endo International Plc, Teva Pharmaceutical Industries Ltd., and Amneal Pharmaceuticals Inc. were hit with federal antitrust claims in Philadelphia over their alleged scheme to delay generic versions of Takeda’s gout drug Colcrys and share in the “monopoly profits” it earned.

The lawsuit, filed late Thursday in the U.S. District Court for the Eastern District of Pennsylvania, accuses the drugmakers of forming a “sham joint venture” to market “authorized generic” versions of Colcrys while putting the brakes on competing versions developed by Amneal, Watson Laboratories Inc., and Endo unit Par Pharmaceutical Inc. Watson ...